3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Oxaliplatin
9
Leucovorin
8
Fluorouracil
8
Bevacizumab
6
Cetuximab
5
Specimen Handling
4
fludarabine
3
Pemetrexed
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
pembrolizumab
2
encorafenib
2
dehydroftorafur
2
aldesleukin
2
Laparoscopy
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Conversion to Open Surgery
2
Cisplatin
2
Celecoxib
2
Carboplatin
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
sapanisertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Valproic Acid
×
30 days
×
Clear all
No trials found.